Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Peregrine Ventures is a venture capital fund established in 2001 and based in Or Yehuda, Israel. It is recognized as Israel's first dedicated healthcare fund, focusing on advancing medical innovation through strategic investments in life sciences. The firm has grown to manage over $300 million in assets, with a portfolio comprising 75 companies as of July 2025. Peregrine Ventures operates from its headquarters in Israel, but its investment strategy encompasses a global reach, particularly targeting opportunities in Asia.
The firm has developed a reputation for its collaborative approach among investment professionals, leveraging deep industry knowledge to support healthcare innovations across various sectors, including medical devices, pharmaceuticals, biotechnology, and digital health. Notable milestones include the successful exits of companies like Insightec and Quicklizard, showcasing the fund's ability to identify and nurture high-potential startups.
Peregrine Ventures invests in life science companies across multiple stages, from pre-seed to late-stage growth. The firm operates several investment vehicles tailored to the needs of companies at different lifecycle stages. The Incentive Incubator focuses on pre-seed investments, providing technological infrastructure and business development support. The Early & Mid Stage Fund targets companies in the seed to Series B range, offering tools and knowledge for business and product development. The Peregrine Growth Fund assists mature companies in their final financing rounds, typically investing $20-30 million per round, particularly in firms approaching IPO or M&A.
The firm emphasizes sectors such as biotech, healthcare, digital health, medical devices, and pharma-tech. Peregrine Ventures seeks to partner with innovative entrepreneurs who are dedicated to making a sustainable impact in healthcare. Their investment strategy is characterized by a commitment to fostering technologies that improve patient outcomes and enhance the quality of life.
Peregrine Ventures has a diverse portfolio of 75 companies, emphasizing innovative technologies in life sciences. Notable portfolio companies include:
This portfolio reflects Peregrine Ventures' commitment to advancing medical innovation and supporting companies that are at the forefront of healthcare technology.
Eyal Lifschitz: Cofounder & Managing General Partner. Eyal has extensive experience in venture capital and has led numerous successful investments in the life sciences sector.
Boaz Lifschitz: Cofounder & Managing General Partner. Boaz brings a wealth of knowledge in healthcare investments and has been instrumental in the growth of Peregrine Ventures.
Lior Shahory: General Partner. Lior specializes in identifying promising life science startups and has a strong track record in the industry.
Elazer R. Edelman: Chairman of the Medical Advisory Board. Elazer is a renowned expert in medical technology and provides strategic guidance to the firm.
Tamir Tal: Venture Partner. Tamir focuses on business development and has a background in healthcare entrepreneurship.
Tal Carasso: Venture Partner, Director of Investor Relations, Business Development. Tal manages investor relations and supports portfolio companies in their growth strategies.
David (Dudi) Eldar: Venture Partner, CFO. Dudi oversees financial operations and ensures the firm’s investments align with its strategic goals.
Shiran Tehila Mashiah: Principal, Pharma/Biotech. Shiran focuses on investments in the pharmaceutical and biotechnology sectors.
Amit Alfasi: Investor Relations and Communications. Amit manages communications and investor relations for the firm.
Ruben Schächter: Investment Director & Head of Europe. Ruben leads investment efforts in European markets.
Vered Zarger: Senior Accounting Manager. Vered oversees accounting and financial reporting.
Tamar Ben-Zvi: Diagnostics, Business Development. Tamar focuses on business development in the diagnostics sector.
Anna Harel: Financial Controller. Anna manages financial controls and reporting.
Inbal Rahamim: Financial Controller. Inbal supports financial operations and reporting.
Liat Gabay: Office Manager. Liat manages office operations and administrative support.
To pitch to Peregrine Ventures, founders should visit their website at peregrinevc.com. The firm prefers comprehensive decks that outline the business model, market opportunity, and technology details. While there is no formal application portal, a well-structured pitch can significantly enhance the chances of engagement.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are beneficial, as they can facilitate initial conversations and increase the likelihood of receiving feedback.
Peregrine Ventures operates several investment programs designed to support companies at different stages of development. The **Incentive Incubator** focuses on pre-seed investments, providing essential technological infrastructure, financial management, and business development support to early-stage healthcare companies.
The **Early & Mid Stage Fund** targets companies in the seed to Series B range, offering tools and knowledge for business and product development. The **Peregrine Growth Fund** assists mature companies in their final financing rounds, typically investing $20-30 million in firms approaching M&A or IPO. These programs reflect Peregrine Ventures' commitment to advancing medical innovation and supporting the growth of life sciences companies.
In the past year, Peregrine Ventures has made significant strides in the life sciences sector. The firm has announced two new investments, further expanding its portfolio of innovative healthcare companies. Notable recent activities include blog posts discussing advancements in technologies such as EndoPulse and Aluma, indicating ongoing engagement with the life sciences community.
Additionally, Peregrine Ventures has been featured in various media outlets, including the Jerusalem Post and Times of Israel, highlighting its role in supporting healthcare innovations. The firm continues to strengthen its presence in the venture capital landscape, particularly within the biotech and healthcare sectors.
What are Peregrine Ventures' investment criteria?
Peregrine Ventures invests in life science companies at various stages, focusing on sectors such as biotech, healthcare, digital health, medical devices, and pharma-tech. The firm looks for innovative entrepreneurs who are dedicated to making a sustainable impact in healthcare.
How can startups apply or pitch to Peregrine Ventures?
Startups can pitch to Peregrine Ventures through their website at peregrinevc.com. It is advisable to include a comprehensive business plan and details about the technology or product being developed.
What makes Peregrine Ventures different from other VC firms?
Peregrine Ventures is distinguished by its focus on life sciences and its collaborative approach among investment professionals. The firm provides extensive support beyond capital, including business strategy, team recruitment, and regulatory navigation.
What is the geographic scope of Peregrine Ventures?
The firm has a global investment strategy with a particular interest in opportunities within Asia. This allows them to tap into emerging markets and innovative healthcare solutions worldwide.
What is the typical check size for investments?
Peregrine Ventures typically invests between $20 million to $30 million in late-stage companies, particularly those nearing M&A or IPO. For earlier-stage investments, the check size may vary based on the specific needs of the company.
What kind of post-investment involvement does Peregrine Ventures have?
Peregrine Ventures offers significant post-investment support, including board involvement, management support, and assistance with strategic alliances. This ensures that portfolio companies have the resources needed to succeed.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.